Hospital de Caridade de Ijui ( Site 2712)

Ijuí, Rio Grande do Sul 98700-000

0 studies enrolling now · 2 studies all time

What they study most

Endometrial Neoplasms, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms

Studies at this site

• Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) — Completed
• Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) — Completed